RDInvesting Provides Investors with Free In-Depth Equity Reports on CACI, PCRX, SLXP and WYNN


Follow this company

Companies Mentioned

NYSE:CACI / NASDAQ:PCRX / NASDAQ:SLXP / NASDAQ:WYNN
03/19/2014 [ACCESSWIRE]

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous s stock reports and market updates.

CACI International Inc. (NYSE: CACI) shares gained 2.23 percent to close at $77.49 a share Tuesday. The stock traded between $76.63 and $78.66 on volume of 546,160 shares traded. Analysts at RBC Capital Markets have recently upgraded the company’s rating to “sector perform” from “underperform”. Shares of CACI International have gained approximately 6.0 percent year-to-date.

Find out more about CACI International including full access to the free equity report at:      
www.RDInvesting.com/CACI

Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) shares gained 4.80 percent to close at $74.93 a share Tuesday. The stock traded between $72.25 and $74.94 on volume of 447,261 shares traded. Analysts at National Alliance Securities have recently initiated coverage on the company with a “buy” rating. Shares of Pacira Pharmaceuticals have gained approximately 30.0 percent year-to-date.

Find out more about Pacira Pharmaceuticals including full access to the free equity report at:     
www.RDInvesting.com/PCRX

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) shares increased 1.85 percent to close at $114.26 a share Tuesday. The stock traded between $112.00 and $114.43 on volume of 724,122 shares traded. Analysts at National Alliance Securities have recently initiated coverage on the company with a “buy” rating. Shares of Salix Pharmaceuticals have gained approximately 27.0 percent year-to-date.

Find out more about Salix Pharmaceuticals including full access to the free equity report at:      
www.RDInvesting.com/SLXP

Wynn Resorts, Limited (NASDAQ: WYNN) shares increased 0.45 percent to close at $234.32 a share Tuesday. The stock traded between $232.09 and $236.90 on volume of 894,838 shares traded. Analysts at Ascendiant have recently initiated coverage on the company with a “hold” rating. Shares of Wynn Resorts have gained approximately 20.0 percent year-to-date.

Find out more about Wynn Resorts including full access to the free equity report at:        
www.RDInvesting.com/WYNN

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:                
Research Driven Investing      
info@rdinvesting.com

COMMENTS

Leave a comment...
 * 

Your Name
 *